In type 4 RTA, which statement about management is true?

In type 4 RTA, which statement about management is true?

• A. Correct hyperkalemia
• B. Initiate ACE inhibitors
• C. Bicarbonate only is sufficient
• D. Potassium intake should be increased

Answer: (A)

Type 4 RTA is a form of renal bicarbonate loss with high potassium because of reduced aldosterone effect or resistance, so the central goal in treatment is to lower the dangerous hyperkalemia while addressing the acidosis and underlying cause. Correcting the high potassium is essential because hyperkalemia drives cardiac risks and reflects the failure to excrete potassium in the collecting ducts. Management focuses on reducing potassium intake, using measures to promote its excretion or shift, and considering mineralocorticoid replacement (like fludrocortisone) if there is true hypoaldosteronism or aldosterone resistance, alongside treating the underlying condition. ACE inhibitors or ARBs would worsen hyperkalemia by further decreasing aldosterone, so they’re not used here. Bicarbonate therapy can help with acidosis but does not reliably correct the potassium problem by itself, so relying on bicarbonate alone is not sufficient. Increasing potassium intake would worsen the hyperkalemia, which is why that approach is inappropriate.

Type 4 RTA is a form of renal bicarbonate loss with high potassium because of reduced aldosterone effect or resistance, so the central goal in treatment is to lower the dangerous hyperkalemia while addressing the acidosis and underlying cause. Correcting the high potassium is essential because hyperkalemia drives cardiac risks and reflects the failure to excrete potassium in the collecting ducts. Management focuses on reducing potassium intake, using measures to promote its excretion or shift, and considering mineralocorticoid replacement (like fludrocortisone) if there is true hypoaldosteronism or aldosterone resistance, alongside treating the underlying condition. ACE inhibitors or ARBs would worsen hyperkalemia by further decreasing aldosterone, so they’re not used here. Bicarbonate therapy can help with acidosis but does not reliably correct the potassium problem by itself, so relying on bicarbonate alone is not sufficient. Increasing potassium intake would worsen the hyperkalemia, which is why that approach is inappropriate.